Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
- 1 September 2011
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 10 (10) , 881-890
- https://doi.org/10.1016/s1474-4422(11)70154-5
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 29 references indexed in Scilit:
- Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationshipsBMC Neurology, 2010
- A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and GabapentinClinical Pharmacokinetics, 2010
- When clinical trials make history: Demonstrating efficacy of new antiepileptic drugs as monotherapyEpilepsia, 2010
- The descriptive epidemiology of epilepsy—A reviewEpilepsy Research, 2009
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled StudyEpilepsia, 2005
- Pregabalin As Adjunctive Therapy for Partial SeizuresEpilepsia, 2004
- Pregabalin Pharmacology and Its Relevance to Clinical PracticeEpilepsia, 2004
- Pregabalin Add‐on Treatment: A Randomized, Double‐blind, Placebo‐controlled, Dose–Response Study in Adults with Partial SeizuresEpilepsia, 2003
- Hazards of Inference: The Active Control InvestigationEpilepsia, 1989